HealthTree Logo
search more_vert
person Sign In / Create Account
Detroit Myeloma Roundtable
Detroit Myeloma Roundtable image
HealthTree Roundtables for Multiple Myeloma
Can't make it to the event?
Sign up and receive the event recording by email

Event Description

Join us for the Detroit Myeloma Round Table at the Radisson Hotel Southfield Detroit, October 12th from 9:00 am-2:30 pm EDT to hear from top myeloma researchers. The day includes informative and engaging presentations about the latest in myeloma as well as breakout sessions for both newly diagnosed and relapsed/refractory patients. The event will feature two sessions that include extensive Q&A. Registration opens at 8:00 am.



  • Meeting date: Saturday, October 12, 2024
  • Registration opens at 8:00 am, meeting begins at 9:00 am
  • Location: Radisson Hotel Southfield Detroit, 26555 Telegraph Rd, Southfield, MI 48033, USA
  • Registration, parking, breakfast, lunch and refreshments are free
  • The meeting will be recorded and available to watch at a later time 
  • Nearest Airport: Detroit Metropolitan Wayne County Airport (DTW)



If you can't make the meeting in person, please register to watch the recording. We will send an email out to all recording registrants about a week following the live meeting.



If you are traveling to the meeting and would like to make a weekend of it while you are in Detroit, here are some suggestions:



For questions about registration, contact us at +1-800-709-1113 or

For all other questions, contact Elisabeth at


Special Thanks to our Health Tree Round Table for Multiple Myeloma Sponsors!

Schedule & Agenda

The panelist Jenny Ahlstrom
Jenny Ahlstrom - Welcome
9:00 AM
Jenny Ahlstrom
  • Introduction and Meeting Logistics
The panelist Morie Gertz, MD, MACP
Multiple Myeloma: Past, Present and Personalized
9:15 AM
Morie Gertz, MD, MACP
  • The history of myeloma innovation
  • Myeloma's unique presentation in each patient
  • The progression from precursor to active dieases
  • Personalizing care
The panelist Craig E. Cole, M.D.
All Myeloma Therapies For All Patients
9:45 AM
Craig E. Cole, M.D.
  • Getting new therapies to all clinics
  • Clinical trial representation for all patients: challenges and solutions
  • Racial differences and outcomes in trials and the real world
10:15 AM
The panelist Matthew Pianko, MD
The Evolving World of Immunotherapies
10:30 AM
Matthew Pianko, MD
  • The who, what, when and why of CAR T
  • The who, what, when and why of bispecific antibodies
The panelist Jennifer Ahlstrom
HealthTree Cure Hub
11:00 AM
Jennifer Ahlstrom
Breakout Sessions
11:15 AM

Richa Parikh, MD - Newly Diagnosed Multiple Myeloma (NDMM) Breakout Session: Diet and Myeloma for MGUS, SMM and Newly Diagnosed Patients


Craig Cole, MD - Relapsed/Refractory Multiple Myeloma (RRMM) Breakout Session: Immunotherapy Strategies in Relapsed Myeloma

12:00 PM
The panelist Jeffrey Zonder, M.D.
Up and Coming Investigational Therapies in Myeloma
1:00 PM
Jeffrey Zonder, M.D.
  • The evolution of CELMoDs
  • Targeting 11:14 with BCL-2 inhibitors
  • Protein degraders and more
Round Table Audience Q&A with Faculty
1:30 PM
Help with HealthTree
2:15 PM
  • Meet the HealthTree team
  • Get educated with HealthTree programs
  • Raffle at 2:15 p.m.

Speakers & Moderators

The panelist Jeffrey Zonder, M.D.
Jeffrey Zonder, M.D.

Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and co-leader of Molecular Therapeutic Program. He is e member of the Steering Committee at the Multiple Myeloma Research Consortium, a medical advisor for the Amyloidosis Support Group Networks, and a member of the International Myeloma Working Group, the International Myeloma Society and the International Amyloidosis Society. He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis. He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York. He received his medical degree from Wayne State University School of Medicine.

Read Bio
The panelist Craig E. Cole, M.D.
Craig E. Cole, M.D.

Craig Emmitt Cole, M.D. is a board-certified Hematologist who received his Bachelor of Science degree in physiology at Michigan State University and the College of Lyman Briggs, in East Lansing Michigan. Dr. Cole went on to receive his doctoral degree at the Ohio State University College of Medicine in Columbus, Ohio. He completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan Health System, Ann Arbor, Michigan. Dr. Cole subsequently had a post-fellowship laboratory research position at the Jerome Lipper Multiple Myeloma Center of Medicine at Dana-Farber Cancer Institute in Boston, Massachusetts. This opportunity then led to him becoming an attending hematologist at Gundersen Health System in La Crosse, Wisconsin for 9 years. There he was an instructor for both the medical and nursing schools of the western campus of the University of Wisconsin School of Medicine and Public Health. He also served as Affiliate Faculty Member of Graduate Community Health Programs and Assistant Professor (Adjunct) at the University of Wisconsin-La Crosse, Department of Health Professions. While in Wisconsin, his clinical research interest was in multiple myeloma, malignant hematology, clinical apheresis, and patient reported outcomes in hematology. He then returned to the University of Michigan Rogel Cancer Center in Ann Arbor, Michigan as an Assistant Professor in the Division of Hematology/Oncology with his primary clinical and research interest being in multiple myeloma. In May of 2019, he returned to Michigan State University College of Human Medicine at Breslin Cancer Center as the Director of Clinical Research in Hematology/ Oncology and Multiple Myeloma. Dr. Cole has been participated in over 50 clinical trials in Multiple Myeloma and Malignant Hematology. He is a member of the International Myeloma Working Group, International Myeloma Society and the American Society of Hematology; he has published in national journals and presented at the American Society of Hematology International Myeloma Workshop, and the American Society for Apheresis meetings. He has lectured across the United States to patients, researchers and clinical providers in multiple myeloma, plasma cell dyscrasias, and disparities in cancer care. He has won awards for his work in student and resident teaching, multiple myeloma research, and patient advocacy. Dr. Cole has always had a strong commitment to equity of cancer care, patient empowerment, and community education by working with several local and national patient advocacy associations to bring the good news of myeloma research to everyone.

Read Bio
The panelist Morie Gertz, MD, MACP
Morie Gertz, MD, MACP

Morie Gertz, MD, MACP, is the Roland Seidler, Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, MN. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Gertz has also served as Treasurer of the International Myeloma Society and President of Mayo Staff Officers and Councilors. He was the Chair of the Mayo Personnel Committee. Currently he serves on the American Society of Hematology Training Program Committee and the American Board of Internal Medicine Hematology Board Exam Committee. Dr. Gertz has been recognized with the 2014 Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström Macroglobulinemia and is a Mayo Distinguished Clinician. He has been recognized for his contributions in amyloidosis and Waldenström macroglobulinemia, has authored more than five hundred peer-reviewed publications, and is a master of the America College of Physicians. He graduated from Northwestern University with highest distinction as a Phi Beta Kappa and received his medical degree cum laude from Loyola Medical School and was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush Presbyterian St. Luke’s Hospital in Chicago and was twice voted Resident of the Year.

Read Bio
The panelist Matthew Pianko, MD
Matthew Pianko, MD

I am a hematologist focused on the care of patients with plasma cell disorders, including Multiple Myeloma, Smoldering Multiple Myeloma, Light chain (AL) amyloidosis, Plasma Cell Leukemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), POEMS syndrome, and Monoclonal Gammopathy of Renal Significance (MGRS). I am committed to providing compassionate patient-centered care for patients with myeloma and other plasma cell disorders.

Read Bio
The panelist Richa Parikh, MD
Richa Parikh, MD

Dr. Richa Parikh received her medical degree from Grant Government Medical College & Sir J.J. Group of Hospitals in Mumbai, India, in 2014. She completed her Internal Medicine residency training from University of Arkansas for Medical Sciences (UAMS), Little Rock, AR in 2019. She then served as an Assistant Professor/academic hospitalist on the multiple myeloma service at UAMS/Myeloma Institute for Research and Therapy, Little Rock, AR, 2019-2021. She is currently a third-year Hematology/Oncology fellow at Karmanos Cancer Institute/Wayne State University, Detroit, MI with a clinical and research interest in multiple myeloma and plasma cell dyscrasias. She will be joining Emory University as Assistant Professor/myeloma faculty in Fall 2024.

Read Bio
The panelist Jenny Ahlstrom
Jenny Ahlstrom
Lehi, Utah

HealthTree Foundation Founder and President, Blood Cancer Survivor

Read Bio


Radisson Hotel Radisson Hotel Southfield Detroit

26555 Telegraph Rd, Southfield, MI 48033, USA

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube